CIK 0001422142 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 7.1 M | 24.4 M | 15.2 M | |
| Net income (USD) | -60.5 M | -110.1 M | ||
| Diluted EPS (USD/shares) | -0.33 | -2.44 | -2.69 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-18 | 4/A | 4/A | 2026-09-15 |
| 2026-09-18 | 4/A | 4/A | 2026-09-15 |
| 2026-09-18 | 4/A | 4/A | 2026-09-15 |
| 2026-09-18 | 4/A | 4/A | 2026-09-15 |
| 2026-09-18 | 4/A | 4/A | 2026-09-15 |
| 2026-09-15 | 4 | 4 | 2026-09-15 |
| 2026-09-15 | 4 | 4 | 2026-09-15 |
| 2026-09-15 | 4 | 4 | 2026-09-15 |
| 2026-09-15 | 4 | 4 | 2026-09-15 |
| 2026-09-15 | 4 | 4 | 2026-09-15 |
| 2026-09-11 | 4 | 4 | 2026-09-09 |
| 2026-09-11 | 3 | 3 | 2026-09-09 |
| 2026-09-10 | 8-K | 8-K items 5.02,9.01 | 2026-09-09 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-07-30 | 4 | 4 | 2026-05-14 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
Forms on file (last 1,000): 4 217, 8-K 110, 10-Q 54, 3 37, SC 13D/A 19, DEFA14A 18, 10-K 18, 424B3 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=WHWK (0.002 USD), /gw/filings/filings?ticker=WHWK&form=8-K, /gw/filings/facts?ticker=WHWK&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange